REMUS2026-09-02REMUS2026-09-022026-09-02iso4217:INRxbrli:pure000000REMUS PHARMACEUTICALS LIMITEDREMUSNOTLISTEDINE0O5T01011NewAcquisition of “to be incorporated companies”true2026-09-0217:30:002026-09-02Since the Company is yet to be incorporated, certain fields, such as the date of incorporation and consideration, are mandatory. Accordingly, the Company has entered 0 under consideration, as the actual consideration will be updated or informed after incorporation of the Company. Further, as the system requires a date of incorporation to be entered mandatorily, today’s date has been mentioned for the time being. <BR> <BR> The same may kindly be read in the context that the Company is yet to be incorporated.REMUS PHARMACEUTICALS LIMITEDListed Entity (self)Not applicable as the entity is yet to be incorporatedPharmaceuticalsThe proposed entity is to be incorporated with the primary objective to undertake the business of supply and distribution of pharmaceutical product in Dominican Republic marketYesAs per the regulatory and statutory laws prevailing in Dominican RepublicCash0Cash consideration. The Company shall subscribe 51% or more of the initial paid-up share capital of the proposed subsidiary.Cost/PriceNot applicable as entity is yet to be incorporated0.512026-09-02Dominican RepublicCompany will hold 51% or more shareholding of the proposed subsidiary